NSC |
Compound |
Enrichment |
Correlation |
NSC 703107 |
Null |
0.0375780807984392 |
0.117302 |
NSC 704565 |
Null |
0.0375780807984392 |
0.36812909 |
NSC 276371 |
2,5-Cyclohexadiene-1,4-dione, 2,3-dimethoxy-5-[(3,7,11,15-tetramethyl-2-hexadecenyl)thio]-, [R-[R*,R*-(E)]]- |
0.0430505868034758 |
0.11778781 |
NSC 622124 |
Molybdate(6-), hexatriaconta-.mu.-oxooctadecaoxobis[.mu.9-[phosphato(3-)-.kappa.O:.kappa.O:.kappa.O:.kappa.O':.kappa.O':.kappa.O'':.kappa.O'':.kappa.O''':.kappa.O''']]octadeca-, hexapotassium (9CI) |
0.0430505868034758 |
0.22120845 |
NSC 681643 |
Camptothecin Derivative |
0.0430505868034758 |
0.11276918 |
NSC 681646 |
Camptothecin Derivative |
0.0430505868034758 |
0.143054 |
NSC 710549 |
Null |
0.0430505868034761 |
0.52150277 |
NSC 722854 |
1,4-di-N-oxide-2-phenylcarbonyl-3-trifluoromethylquinoxaline |
0.0430505868034761 |
0.46541347 |
NSC 723732 |
8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one |
0.0430505868034761 |
0.266731 |
NSC 732178 |
Null |
0.0430505868034761 |
0.019232521 |